نتائج البحث 301-310 من 23103 لعملية البحث عن Treatment
... treatment (refractory). A Study To Evaluate Azacitidine Plus Venetoclax Induction Chemotherapy To Treat Acute Myeloid Leukemia Patients For T-cell Directed ...
... treatment in patients with recurrent grade 2 or 3 meningioma as measured by 6-month PFS rate. Mayo Clinic Cancer Center Neuro-Oncology Program Registry And ...
This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that has ...
Usual treatment after a complete response may include observation or high dose chemotherapy followed by an autologous stem cell transplant, however, it is ...
This gene allows the T cells to recognize and possibly treat the cancer. The new modified T cells are called the IC19/1563 treatment. The dose of IC19/1563 will ...
Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The ...
Treatment Resistant Depression Subcallosal Cingulate Network. Rochester, Minn. The purpose of this study is to evaluate the effectiveness and safety of ...
... treatment of high levels of pre-loss grief among family caregivers (FCG) of persons nearing the end of life. A Registry Study For The Long-Term Outcomes Of ...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Aggressive Malignancy PDX (Avatar) and ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.